Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia
Ettore Biagi, Raphael Rousseau, Eric Yvon, et al.
Cytotherapy
|
March 13, 2022
Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study
Laarni Ibenana, Robert Anderson, Adrian Gee, et al.
Neurosurgery
|
December 31, 2010
Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children
Charles S Cox, James E Baumgartner, Matthew T Harting, et al.
The Journal of Experimental Medicine
|
December 22, 2004
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease
Catherine M Bollard, Laura Aguilar, Karin C Straathof, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 16, 2010
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma
Chrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 13, 2017
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
Andras Heczey, Chrystal U Louis, Barbara Savoldo, et al.
Blood
|
June 3, 2006
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Persis J Amrolia, Giada Muccioli-Casadei, Helen Huls, et al.
Blood
|
October 31, 2002
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
Raphaël F Rousseau, Ann E Haight, Charlotte Hirschmann-Jax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2011
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy
Guru Sonpavde, Timothy C Thompson, Rajul K Jain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients
Susann Szmania, Natalia Lapteva, Tarun Garg, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia
Ettore Biagi, Raphael Rousseau, Eric Yvon, et al.
Cytotherapy
|
March 13, 2022
Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study
Laarni Ibenana, Robert Anderson, Adrian Gee, et al.
Neurosurgery
|
December 31, 2010
Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children
Charles S Cox, James E Baumgartner, Matthew T Harting, et al.
The Journal of Experimental Medicine
|
December 22, 2004
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease
Catherine M Bollard, Laura Aguilar, Karin C Straathof, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 16, 2010
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma
Chrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 13, 2017
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
Andras Heczey, Chrystal U Louis, Barbara Savoldo, et al.
Blood
|
June 3, 2006
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Persis J Amrolia, Giada Muccioli-Casadei, Helen Huls, et al.
Blood
|
October 31, 2002
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
Raphaël F Rousseau, Ann E Haight, Charlotte Hirschmann-Jax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2011
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy
Guru Sonpavde, Timothy C Thompson, Rajul K Jain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients
Susann Szmania, Natalia Lapteva, Tarun Garg, et al.
Page
of 3